Evidence map›Paper›PMID 35203562›Full record

ArticleBiomedicines2022

Pathophysiological Response to SARS-CoV-2 Infection Detected by Infrared Spectroscopy Enables Rapid and Robust Saliva Screening for COVID-19.

Seth T Kazmer, Gunter Hartel, Harley Robinson, Renee S Richards, Kexin Yan, Sebastiaan J van Hal, Raymond Chan, Andrew Hind, David Bradley, Fabian Zieschang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Seth T KazmerPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Gunter HartelBiostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.ORCID 0000-0002-5454-6450
Harley RobinsonPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.ORCID 0000-0002-9374-5532
Renee S RichardsPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Kexin YanInflammation Biology Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Sebastiaan J van HalNew South Wales Health Pathology-Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Raymond ChanNew South Wales Health Pathology-Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Andrew HindAgilent Technologies Australia, Mulgrave, VIC 3170, Australia.
David BradleyAgilent Technologies Australia, Mulgrave, VIC 3170, Australia.
Fabian ZieschangAgilent Technologies Australia, Mulgrave, VIC 3170, Australia.
Daniel J RawleInflammation Biology Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.ORCID 0000-0001-7248-0101
Thuy T LeInflammation Biology Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
David W ReidLung Inflammation & Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Andreas SuhrbierInflammation Biology Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.ORCID 0000-0001-8986-9025
Michelle M HillPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.ORCID 0000-0003-1134-0951
QIMR Berghofer Medical Research Institute · AUAgilent Technologies (Australia) · AURoyal Prince Alfred Hospital · AUThe University of Queensland · AU

Funding

Agilent Technologies Applications & Core Technology - University Research GrantQIMR Berghofer Medical Research Institute COVID ResearchThe Prince Charles Hospital Foundation COVID Research
6 · The paper itself

Abstract

Fourier transform infrared (FTIR) spectroscopy provides a (bio)chemical snapshot of the sample, and was recently used in proof-of-concept cohort studies for COVID-19 saliva screening. However, the biological basis of the proposed technology has not been established. To investigate underlying pathophysiology, we conducted controlled infection experiments on Vero E6 cells in vitro and K18-hACE2 mice in vivo. Potentially infectious culture supernatant or mouse oral lavage samples were treated with ethanol or 75% (

Indexed as

COVID-19 pandemicfourier transform infrared spectroscopyFTIRkallikrein

Identifiers

PMID35203562
PMCPMC8962262
OpenAlexW4210309366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.